Physician
NPI deactivated
Allergy Arts LLP
Allergy Arts LLP was paid $3.55M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 25% of everything it billed.
33Billing provider infoALLERGY ARTS LLP
AMARILLO, TX 79124
AMARILLO, TX 79124
33aNPI1659342061assigned 02/01/2006
33bProvider typeAllergy & Immunology (Internal Medicine) Physician
28Total paid$3.55M
24GClaims85,535
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Allergy & Immunology (Internal Medicine) Physician providers in Texas
Rank by total paid#1 of 6
Median peer was paid$878K
This provider vs. median4.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,644 | $8K | |
| 2019 | 5,618 | $8K | |
| 2020 | 6,844 | $225K | |
| 2021 | 18,241 | $874K | |
| 2022 | 18,438 | $1.13M | |
| 2023 | 20,278 | $902K | |
| 2024incomplete | 11,472 | $397K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 25% | 369 | 282 | $884K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 17% | 1,408 | 1,246 | $619K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 10,359 | 9,405 | $562K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 15% | 2,011 | 1,894 | $536K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.5% | 2,180 | 1,903 | $196K |
| 95117 | 4.5% | 16,770 | 5,999 | $159K | |
| 94728 | 2.8% | 2,804 | 2,690 | $101K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 1,738 | 1,635 | $86K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 524 | 506 | $74K |
| 96401 | 1.9% | 990 | 636 | $69K | |
| 80053 | Comprehensive metabolic panel | 1.1% | 6,871 | 6,288 | $40K |
| 86235 | 1.1% | 366 | 313 | $40K |
47 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,411 | $33K |
| 86140 | <1% | 6,953 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,326 | $20K |
| 86225 | <1% | 1,068 | $12K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 138 | $12K |
| 85652 | <1% | 6,819 | $11K | |
| 86038 | <1% | 1,079 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 932 | $10K |
| 86160 | <1% | 586 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 352 | $6K |
| 76881 | <1% | 135 | $6K | |
| 80074 | <1% | 147 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 98 | $4K |
| 20611 | <1% | 94 | $3K | |
| 94729 | <1% | 81 | $3K | |
| 94726 | <1% | 56 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 186 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 112 | $1K |
| 82570 | <1% | 272 | $1K | |
| 82728 | <1% | 85 | $1K | |
| 81001 | <1% | 406 | $1K | |
| 84156 | <1% | 311 | $966.94 | |
| 83970 | <1% | 30 | $884.34 | |
| 87400 | <1% | 63 | $765.83 | |
| 95012 | <1% | 265 | $736.19 | |
| 83516 | <1% | 90 | $676.32 | |
| 73110 | <1% | 23 | $603.82 | |
| 73130 | <1% | 23 | $529.67 | |
| 82607 | <1% | 45 | $487.92 | |
| 96415 | <1% | 16 | $459.28 | |
| 83550 | <1% | 54 | $403.70 | |
| 83540 | <1% | 68 | $364.03 | |
| 94010 | <1% | 13 | $312.44 | |
| 82746 | <1% | 29 | $308.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15 | $250.08 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,545 | $215.91 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $200.14 |
| 86200 | <1% | 16 | $163.20 | |
| 82785 | <1% | 16 | $159.95 | |
| 86430 | <1% | 16 | $154.80 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 19 | $108.64 |
| 82550 | <1% | 16 | $90.31 | |
| 83735 | <1% | 12 | $50.70 | |
| 84100 | <1% | 15 | $43.78 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,985 | $33.98 |
| 84550 | <1% | 16 | $28.50 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 95 | $16.01 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAADEH, CONSTANTINE (PRESIDENT)